Evidence map›Paper›PMID 24867395›Full record

ArticleMayo Clinic proceedings2014

The consequences of chronic kidney disease mislabeling in living kidney donors.

Colin R Lenihan, Jane C Tan

Abstract readCase Reports
In one paragraph

Article in Mayo Clinic proceedings, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Colin R LenihanDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA. Electronic address: clenihan@stanford.edu.
Jane C TanDivision of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA.

Funding

Renal senescence in kidney donorsK23DK087937 · NIDDK · STANFORD UNIVERSITY · PI TAN, JANE C · 2010 to 2014
$892k
NIDDK NIH HHS K23 DK087937
6 · The paper itself

Abstract

Despite numerous studies that substantiate its long-term safety, barriers to kidney donation persist. These include issues of insurability after donation and its consequent financial and emotional burdens. We present 2 cases in which mislabeling of kidney donors as having chronic kidney disease shortly after kidney donation adversely affected their insurability. A concerted effort should be made to affect public policy such that insurability and the psychosocial well-being of living donors are protected.

Indexed as

Kidney TransplantationDiagnostic ErrorsFemaleGlomerular Filtration RateHumansInsurance CoverageInsurance, HealthInsurance, LifeLiving DonorsMaleMiddle AgedNephrectomyRenal Insufficiency, Chronic

Identifiers

PMID24867395
PMCPMC5096430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.